- 1.00 AMA PRA Category 1 Credit(s)™AMA PRA Category 1 Credit(s)™
- 1.00 Hours of ParticipationHours of Participation credit.
In November 2000, Amendment 20 was passed in Colorado which legalized limited amounts of medical marijuana for patients and their primary caregivers. In November 2012, Amendment 64 was passed in Colorado which legalized recreational marijuana by decriminalizing the possession of marijuana and regulating the sale of marijuana. On January 1, 2014 recreational marijuana stores opened to the public. As of April 2018, twenty-nine (29) states (includes the District of Columbia) have legalized marijuana for medical use. Included in these twenty-nine states are nine states (includes the District of Columbia) which have legalized marijuana for recreational use. As states around the country begin to legalize medical and recreational marijuana, it is important to understand the possible effects of legalization on Toxicological analysis and testimony.
Allied Health Professionals
At the conclusion of this activity, learners will be able to:
- Provide an overview of relevant laws in Colorado and other states with legalized medicinal and/or recreational marijuana.
- Discuss analytical challenges regarding the analysis of marijuana in driving under the influence of drugs (DUID) specimens.
- Describe how to interpret driving under the influence of marijuana blood results and potential challenges in courtroom testimony.
In accordance with the ACCME® standard for Commercial Support Number 6, all in control of content disclosed any relevant financial relationships. The following in control of content had no relevant financial relationships to disclose.